Trending

cluster headache

Lilly’s migraine drug gets key cluster headache approval

Lilly’s migraine drug gets key cluster headache approval

The FDA has approved Eli Lilly’s Emgality (galcanezumab-gnlm) for the treatment of episodic cluster headache in adults, giving

X

Lilly’s migraine drug gets key cluster headache approval

https://pharmaphorum.com/news/lillys-migraine-drug-gets-key-cluster-headache-approval/

Lilly claims fast FDA review for Emgality in cluster headache

Lilly claims fast FDA review for Emgality in cluster headache

Eli Lilly has a battle on its hands in the migraine prevention category with third-to-market CGRP inhibitor Emgality

X

Lilly claims fast FDA review for Emgality in cluster headache

https://pharmaphorum.com/news/lilly-claims-fast-fda-review-for-emgality-in-cluster-headache/

Lilly drug scrapes through cluster headache trial

Lilly drug scrapes through cluster headache trial

FDA to make decision on Amgen drug tomorrow

X

Lilly drug scrapes through cluster headache trial

https://pharmaphorum.com/news/lillys-galcanezumab-scrapes-through-cluster-headache-trial/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com